AstraZeneca PLC - American Depositary Shares — Financial Statistics (NASDAQ:AZN) | MetaTrader

Open full chart

News

Flu season is already here. Here’s what to know about this year’s flu shots.

Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times

Cancer Stocks to Consider as Oncology Innovation Accelerates

Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH

Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results

SOPHiA GENETICS, Myriad Genetics Collaborate To Advance New Prostate Cancer-specific Genomic Instability Score Technology

How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings?

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?

Astrazeneca (AZN) Exceeds Market Returns: Some Facts to Consider

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?

AstraZeneca Announces The Opening Of Its Newest Global Strategic Research And Development Center, In Kendall Square, Cambridge, Massachusetts; Co. invests $1B To Grow Massachusetts Workforce By Over 50%

SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos